We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Regeneron Pharmaceuticals, ...

A bankruptcy court this week approved the $305 million sale of genetics testing firm 23andMe to a nonprofit organization led by the company's former CEO Anne Wojcicki, the company announced. The ...

TTAM Research Institute acquires 23andMe in a $305 million bankruptcy sale, transitioning the DNA testing giant to a ...

After the company filed for bankruptcy in March, this week, the sale of 23andMe was completed after previously being approved by a judge.

Our previous report on the Chapter 11 case of 23andMe discussed the Sale Order entered by the Bankruptcy Court on June 27, ...

A U.S. district judge put on hold the bankruptcy sale of genetic testing company 23andMe late on Monday, giving California three days to make its case that the sale should remain blocked during an ...

CT is your last chance to file a claim with 23andMe for a 2023 data breach that may have compromised your genetic data.

Me’s privacy ombudsman secured court approval to retain WilmerHale in the DNA testing company’s Chapter 11 case despite an ...

DNA from 23andMe after it declared bankruptcy. Now the more than 10 million remaining customers should delete theirs, too.

That means Wojcicki’s nonprofit TTAM Research Institute will purchase “substantially all” of San Francisco-based 23andMe’s assets for $305 million. The transaction — which arrives more than three ...

To qualify for a cybersecurity-related claim, one must be a 23andMe customer between May 1, 2023, and Oct. 1, 2023; have ...

After a couple of months of non-stop litigation, counsel for the debtor at Paul, Weiss and for the acquirer—a newly formed ...